Baluarte, Janet .

HRN: 12-70-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2023
CEFUROXIME 500MG (TAB)
04/12/2023
04/19/2023
PER OREM
500 Mg
Twice A Day For 7 Days
S/P NSVD
Waiting Final Action 
04/12/2023
METRONIDAZOLE 500MG (TAB)
04/12/2023
04/19/2023
PER OREM
500 Mg
Three Times A Day For 7 Days
S/P NSVD
Waiting Final Action 
08/02/2024
CEFUROXIME 1.5GM (VIAL)
08/02/2024
08/02/2024
IV
1.5g
PTOR
CS For Preeclampsia With Severe Features
Waiting Final Action 
08/02/2024
CEFUROXIME 1.5GM (VIAL)
08/02/2024
08/08/2024
IV
1.5
Q8
SP LTCS
Waiting Final Action 
08/02/2024
CEFUROXIME 1.5GM (VIAL)
08/02/2024
08/03/2024
IV
1.5 Grams
Q8
Surgical Prophylaxis
Waiting Final Action 
08/02/2024
CEFUROXIME 500MG (TAB)
08/03/2024
08/09/2024
PO
500 Mg Tab
BID
Sp Ltcs
Waiting Final Action 
08/02/2024
MUPIROCIN 2%, 15G (TUBE)
08/02/2024
08/08/2024
TOPICAL
Apply On Surgical Site
BID
SP LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: